Literature DB >> 1066353

Granuloma formation in patients receiving BCG immunotherapy.

J A Whittaker, D P Bentley, G R Melville-Jones, A J Slater.   

Abstract

Eleven patients with acute myeloblastic leukaemia have received repeated intravenous injections of BCG containing 4-9 X 10(6) live organisms per millilitre. Non-caseating epithelioid granulomas, sometimes with giant-cell formation, have been demonstrated in eight bone marrow aspirates. Seven patients had granulomas in the liver, three in the lung, one in the spleen, one in lymph nodes, and one in a skin biopsy. One patient had a raised serum alkaline phosphatase, but none of the patients had any illness which could be related to the presence of granulomas. Granuloma formation appeared more extensive in four patients who were probably anergic before BCG treatment. Until the significance of this finding becomes clear great care should be taken when giving BCG by the intratumour of intravenous routes to potentially immunoincompetent patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1066353      PMCID: PMC476148          DOI: 10.1136/jcp.29.8.693

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  B.C.G. dissemination in congenital hypogammaglobulinaemia.

Authors:  J BOUTON; D MAINWARING; R W SMITHELLS
Journal:  Br Med J       Date:  1963-06-08

2.  CONGENITAL AGAMMAGLOBULINAEMIA IN THE BROTHER OF A BOY WHO DIED OF GENERALIZED BCG INFECTION.

Authors:  J O BONNEVIER; J KILLANDER; L OLDING; B VAHLQUIST
Journal:  Acta Paediatr       Date:  1964-01       Impact factor: 2.299

3.  On the occurrence of epitheloid cell granulomas in the organs of BCG-vaccinated human beings.

Authors:  H GORMSEN
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1956

4.  Should mass vaccination with BCG be discontinued in Scandinavia?

Authors:  A WALLGREN
Journal:  Acta Paediatr       Date:  1955-05       Impact factor: 2.299

5.  [Experiments with radioactive tubercle bacilli relative to immunity against tuberculosis].

Authors:  L STROM; G WIDSTROM
Journal:  Acta Paediatr       Date:  1951-05       Impact factor: 2.299

6.  Prolonging remission in myeloblastic leukemia by tice-strain bacillus Calmette-Guérin.

Authors:  W R Vogler; Y K Chan
Journal:  Lancet       Date:  1974-07-20       Impact factor: 79.321

7.  Letter: Immunotherapy with intravenous B.C.G.

Authors:  J A Whittaker; J S Lilleyman; A Jacobs; I Balfour
Journal:  Lancet       Date:  1973-12-22       Impact factor: 79.321

8.  Granulomatous hepatitis: a complication of B.C.G. immunotherapy.

Authors:  J S Hunt; M J Silverstein; F C Sparks; C M Haskell; Y H Pilch; D L Morton
Journal:  Lancet       Date:  1973-10-13       Impact factor: 79.321

9.  Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.

Authors:  J U Gutterman; E M Hersh; V Rodriguez; K B McCredie; G Mavligit; R Reed; M A Burgess; T Smith; E Gehan; G P Bodey; E J Freireich
Journal:  Lancet       Date:  1974-12-14       Impact factor: 79.321

10.  Immunotherapy for acute myelogenous leukaemia.

Authors:  R L Powles; D Crowther; C J Bateman; M E Beard; T J McElwain; J Russell; T A Lister; J M Whitehouse; P F Wrigley; M Pike; P Alexander; G H Fairley
Journal:  Br J Cancer       Date:  1973-11       Impact factor: 7.640

View more
  1 in total

1.  Induction and maintenance of a phenotypically heterogeneous lung tissue-resident CD4+ T cell population following BCG immunisation.

Authors:  Naomi C Bull; Daryan A Kaveh; M C Garcia-Pelayo; Elena Stylianou; Helen McShane; Philip J Hogarth
Journal:  Vaccine       Date:  2018-08-07       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.